Voyager Therapeutics Stock (NASDAQ: VYGR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.000 / 634.442K |
Day Range | - - - |
52 Wk Range | 6.060 - 14.340 |
Market Cap | $412.685M |
P/E Ratio | 2.542 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 7.33% |
Days to Cover | 4.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Voyager Therapeutics (NASDAQ: VYGR) through any online brokerage.
Other companies in Voyager Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Humacyte (NASDAQ:HUMA), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and PepGen (NASDAQ:PEPG).
The latest price target for Voyager Therapeutics (NASDAQ: VYGR) was reported by Guggenheim on Tuesday, March 26, 2024. The analyst firm set a price target for 22.00 expecting VYGR to rise to within 12 months (a possible 189.47% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Voyager Therapeutics (NASDAQ: VYGR) is $7.6 last updated April 18, 2024 at 4:31 PM EDT.
There are no upcoming dividends for Voyager Therapeutics.
Voyager Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Voyager Therapeutics.
Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.